Last edition
News about "Neurological Diseases"
Ono Pharma Enters into Drug Discovery Partnership with Aitia in Neurological Diseases
Ono Pharma partners with Aitia to use causal Artificial Intelligence (AI) and Gemini Digital Twins for novel drug target discovery in neurological diseases.
Neurological Diseases | 03/09/2026 | By News Bureau
Marvel Biosciences Reports Positive Preclinical Results for MB-204 in Fragile X Syndrome Study
Marvel Biosciences has reported positive preclinical results for its lead drug candidate, MB-204, in a Fragile X syndrome study conducted with the FRAXA Research Foundation. The findings further support the therapy's potential to treat autism spectrum disorder and related neurodevelopmental conditions.
Neurological Diseases | 06/08/2026 | By News Bureau | 123
Immunic Secures European Patent for Vidofludimus Calcium, Strengthening Long-Term Market Exclusivity
Immunic receives European patent protection for Vidofludimus Calcium dosing regimens, reinforcing intellectual property coverage and potentially extending exclusivity for the multiple sclerosis therapy in Europe until 2043.
Neurological Diseases | 12/03/2026 | By News Bureau | 147
Jaya Biosciences Receives US Patent for Novel Methods of Treating Neurological Diseases
US patent grant to Jaya Biosciences broadens protection and strengthens the company’s leadership in developing CNS-directed therapies for genetically defined neurodegenerative diseases.
Neurological Diseases | 07/11/2025 | By Dineshwori | 388
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy